The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group
- PMID: 2694767
- DOI: 10.1111/j.1600-0447.1989.tb03032.x
The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group
Abstract
Of 49 schizophrenic patients followed up 2 years after their first admission to hospital, 37% were well, 47% had been readmitted to hospital at some time over the 2 years, and 38% showed schizophrenic symptoms at follow-up. A poor outcome at 2 years was associated with male sex, poor outcome after the first 5 weeks of the first admission, negative schizophrenic symptoms on first admission, and a diagnosis of definite or probable schizophrenia using the Feighner criteria. Only 23% were in employment. A small double-blind discontinuation study of maintenance antipsychotic medication during the second year found more relapses in those switched to placebo medication. Repeat psychometric assessment at 2 years confirmed modest improvements found at 12 months; that is, there was no evidence of intellectual decline. Relatives showed no more psychosocial distress than that found in a normal community sample; what distress there was correlated with patients' schizophrenic symptoms.
Similar articles
-
The Scottish First Episode Schizophrenia Study V. One-year follow-up. The Scottish Schizophrenia Research Group.Br J Psychiatry. 1988 Apr;152:470-6. doi: 10.1192/bjp.152.4.470. Br J Psychiatry. 1988. PMID: 3167396
-
The Scottish first episode schizophrenia study. VIII. Five-year follow-up: clinical and psychosocial findings. The Scottish Schizophrenia Research Group.Br J Psychiatry. 1992 Oct;161:496-500. Br J Psychiatry. 1992. PMID: 1393335 Clinical Trial.
-
The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group.Br J Psychiatry. 1987 Mar;150:334-8. doi: 10.1192/bjp.150.3.334. Br J Psychiatry. 1987. PMID: 2889495 Clinical Trial.
-
Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.Br J Psychiatry. 1979 Dec;135:515-23. doi: 10.1192/bjp.135.6.515. Br J Psychiatry. 1979. PMID: 394794 Clinical Trial.
-
The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime.Int Clin Psychopharmacol. 1987 Apr;2(2):141-9. doi: 10.1097/00004850-198704000-00008. Int Clin Psychopharmacol. 1987. PMID: 3298419 Clinical Trial.
Cited by
-
Pharmacological management of first-episode schizophrenia and related nonaffective psychoses.Drugs. 2003;63(21):2265-83. doi: 10.2165/00003495-200363210-00001. Drugs. 2003. PMID: 14524730 Review.
-
Maintenance treatment with antipsychotic drugs for schizophrenia.Cochrane Database Syst Rev. 2020 Aug 11;8(8):CD008016. doi: 10.1002/14651858.CD008016.pub3. Cochrane Database Syst Rev. 2020. PMID: 32840872 Free PMC article.
-
Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.CNS Drugs. 2016 May;30(5):357-68. doi: 10.1007/s40263-016-0331-x. CNS Drugs. 2016. PMID: 27106296 Review.
-
Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.Int J Neuropsychopharmacol. 2022 Sep 28;25(9):737-758. doi: 10.1093/ijnp/pyac002. Int J Neuropsychopharmacol. 2022. PMID: 35451023 Free PMC article. Review.
-
Unanswered questions in schizophrenia clinical trials.Schizophr Bull. 2008 Mar;34(2):302-9. doi: 10.1093/schbul/sbm143. Epub 2008 Jan 16. Schizophr Bull. 2008. PMID: 18199633 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical